Patterns of Substance Use among Patients in Addiction Rehabilitation in Jordan.

References

• Aburuz, S., Bulatova, N., Twalbeh, M., & Gazawi, M. (2009). The validity and reliability of the Arabic version of the EQ-5D: A study from Jordan. Annals of Saudi Medicine, 29(4), 304–308. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19584581 doi:10.4103/0256-4947.55313
   PubMed Web of Science ®Google Scholar
• Al-Husseini, A., Wazaify, M., & Hout, M. C. V. (2017). Pregabalin misuse and abuse in Jordan: A qualitative study of user experiences. International Journal of Mental Health and Addiction, 16, 1–13. doi:10.1007/s11469-017-9813-4
   Web of Science ®Google Scholar
• AlKalaileh, W., Wazaify, M., & VanHout, M. C. (2017). Ophthalmic drug abuse and misuse in Jordan: an observational study for patterns from community pharmacies and survey of ophthalmologists (Msc.). University of Jordan, Amman.
   Google Scholar
• Ali, S. F., Onaivi, E. S., Dodd, P. R., Cadet, J. L., Schenk, S., Kuhar, M. J., & Koob, G. F. (2011). Understanding the global problem of drug addiction is a challenge for IDARS Scientists. Current Neuropharmacology, 9(1), 2–7. doi:10.2174/157015911795017245
   Web of Science ®Google Scholar
• American Psychiatric Association. (2013). Substance related disorders. In C. P. O’Brien & T. J. Crowley (Eds.), Diagnostic and statistical manual of mental disorders; DSM-V (5th ed., pp. 483–589). Washington, DC; Arlington, VA: American Psychiatric Association.
   Google Scholar
• Balbani, A. P. S., Duarte, J. G., de Mello, J. F., D'Antonio, W. E. P., Câmara, J., & Butugan, O. (2000). Toxicity of drugs used for treatment of rhinitis: A reminder to the otorhinolaryngologist. American Journal of Rhinology, 14(2), 77–82. doi:10.2500/105065800781692903
   PubMedGoogle Scholar
• Bastien, C. H., VallieÁres, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307. doi:10.1016/S1389-9457(00)00065-4
   PubMed Web of Science ®Google Scholar
• Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996). Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biological Psychiatry, 39(6), 411–418. doi:10.1016/0006-3223(95)00188-3
   PubMed Web of Science ®Google Scholar
• Cohen, K., & Weinstein, A. M. (2018). Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Front Public Health, 6, 162. doi:10.3389/fpubh.2018.00162
   PubMed Web of Science ®Google Scholar
• Conroy, D. A., & Arnedt, J. T. (2014). Sleep and substance use disorders: An update. Current Psychiatry Reports, 16(10), 487. doi:10.1007/s11920-014-0487-3
   PubMed Web of Science ®Google Scholar
• Darcin, A. E., Dilbaz, N., Yilmaz, S., & Cetin, M. K. (2011). Cyclopentolate hydrochloride eye drops addiction: A case report. Journal of Addiction Medicine, 5(1), 84–85. doi:10.1097/ADM.0b013e3181dd4f90
   PubMed Web of Science ®Google Scholar
• Dijkgraaf, M. G., van der Zanden, B. P., de Borgie, C. A., Blanken, P., van Ree, J. M., & van den Brink, W. (2006). Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug and Alcohol Dependence, 82(2), 111–118. doi:10.1016/j.drugalcdep.2005.08.012
   PubMed Web of Science ®Google Scholar
• Doghramji, K., Tanielian, M., Certa, K., & Zhan, T. (2018). Severity, prevalence, predictors, and rate of identification of insomnia symptoms in a sample of hospitalized psychiatric patients. The Journal of Nervous and Mental Disease, 206(10), 765–769. doi:10.1097/NMD.0000000000000888
   PubMed Web of Science ®Google Scholar
• Economic & Social Council. (2018). Combating Narcotics in Jordan: A strategic framework for general policy. Amman, Jordan: Economic and Social Council.
   Google Scholar
• Feuer, G., Sosalucero, J., & Delaiglesia, F. (1977). Influence of oral contraceptives on the acute effect of amphetamine on the hepatic endoplasmic reticulum of the rat. Toxicology, 7(1), 107–114. doi:10.1016/0300-483X(77)90042-7
   PubMed Web of Science ®Google Scholar
• Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA: The Journal of the American Medical Association, 262(11), 1479–1484. doi:10.1001/jama.262.11.1479
   PubMed Web of Science ®Google Scholar
• G¨Unther, O., Roick, C., Angermeyer, M. C., & K¨Onig, H.-H. (2007). The EQ-5D in alcohol dependent patients: Relationships among health-related quality of life, psychopathology and social functioning. Drug and Alcohol Dependence, 86, 253–264. doi:10.1016/j.drugalcdep.2006.07.001
   PubMed Web of Science ®Google Scholar
• Galea, S., & Vlahov, a.D. (2004). The social epidemiology of substance use. Epidemiologic Reviews, 26(1), 36–52. doi:10.1093/epirev/mxh007
   PubMed Web of Science ®Google Scholar
• Ghaferi, H. A. (2013). A descriptive study of the characteristics of alcohol and drug misusers in a treatment centre, in Amman, Jordan. Aberdeen: University of Aberdeen.
   Google Scholar
• González-Sáiz, F., Domingo-Salvany, A., Barrio, G., Sánchez-Niubó, A., Brugal, M. T., de la Fuente, L., & Alonso, J. (2009). Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence. European Addiction Research, 15(2), 87–93. doi:10.1159/000189787
   PubMed Web of Science ®Google Scholar
• Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (2006). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607–614. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7795497 doi:10.1046/j.1360-0443.1995.9056072.x
   Google Scholar
• Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2014). A survey of synthetic cannabinoid consumption by current cannabis users. Substance Abuse, 35(2), 184–189. doi:10.1080/08897077.2013.846288
   PubMed Web of Science ®Google Scholar
• Hakem Al-Soufi, E. S. M. a.-N., Arar, S. H. (2016). Identification of some synthetic cannabinoids in different matrices by chromatography-mass spectrometry. Amman, Jordan: Al- Balqa University.
   Google Scholar
• Hall, W., Degenhardt, L., & Teesson, M. (2009). Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base. Addictive Behaviors, 34(6–7), 526–530. doi:10.1016/j.addbeh.2009.03.010
   PubMed Web of Science ®Google Scholar
• Hamdan-Mansour, A. M., Al-Sagarat, A. Y., Al-Sarayreh, F., Nawafleh, H., & Arabiat, D. H. (2018). Prevalence and correlates of substance use among psychiatric inpatients. Perspectives in Psychiatric Care, 54(2), 149–155. doi:10.1111/ppc.12214
   PubMed Web of Science ®Google Scholar
• Husseini, R. (2012). Prevention key to combating drug abuse. The Jordan Times.
   Google Scholar
• Kassim, S., Islam, S., & Croucher, R. (2010). Validity and reliability of a Severity of Dependence Scale for khat (SDS-khat). Journal of Ethnopharmacology, 132(3), 570–577. doi:10.1016/j.jep.2010.09.009
   PubMed Web of Science ®Google Scholar
• Kravitz, M., & Nichols, W. (2016). A bitter pill to swallow: Connections between Captagon, Syria, and the Gulf. Journal of International Affairs, 69(2), 31–46.
   Google Scholar
• Lawrinson, P., Copeland, J., Gerber, S., & Gilmour, S. (2007). Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addictive Behaviors, 32(7), 1474–1479. doi:10.1016/j.addbeh.2006.09.005
   PubMed Web of Science ®Google Scholar
• Mahfoud, Y., Talih, F., Streem, D., & Budur, K. (2009). Sleep disorders in substance abusers: How common are they? Psychiatry (Edgmont (Pa.: Township)), 6(9), 38–42.
   PubMedGoogle Scholar
• Martin, G., Copeland, J., Gates, P., & Gilmour, S. (2006). The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off. Drug and Alcohol Dependence, 83(1), 90–93. doi:10.1016/j.drugalcdep.2005.10.014
   PubMed Web of Science ®Google Scholar
• NIDA. National Institute on Drug Abuse. (2018). Synthetic Cannabinoids, under: Drugs of Abuse. Can be retrieved from URL: https://www.drugabuse.gov/drugs-abuse/synthetic-cannabinoids-k2spice. Last accessed on January 29th, 2020.
   Google Scholar
• Peak, J., Goranitis, I., Day, E., Copello, A., Freemantle, N., & Frew, E. (2018). Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health and Quality of Life Outcomes, 16(1), 106. doi:10.1186/s12955-018-0926-7
   PubMedGoogle Scholar
• Rounsaville, B. J., Petry, N. M., & Carrolla, K. M. (2003). Single versus multiple drug focus in substance abuse clinical trials research. Drug and Alcohol Dependence, 70(2), 117–125. doi:10.1016/S0376-8716(03)00033-4
   PubMed Web of Science ®Google Scholar
• Ruglass, L. M., Scodes, J., Pavlicova, M., Campbell, A. N. C., Fitzpatrick, S., Barbosa-Leiker, C., … Nunes, E. V. Jr. (2019). Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone. Drug and Alcohol Dependence, 205, 107649. doi:10.1016/j.drugalcdep.2019.107649
   PubMed Web of Science ®Google Scholar
• Schifano, F. (2019). Recent changes in drug abuse scenario: The Novel Psychoactive Substances (NPS) Phenomenon.
   Google Scholar
• Suleiman, K. H., & Yates, B. C. (2011). Translating the insomnia severity index into Arabic. Journal of Nursing Scholarship, 43(1), 49–53. doi:10.1111/j.1547-5069.2010.01374.x
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. (1990). EuroQol - a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.
   PubMed Web of Science ®Google Scholar
• Topp, L., & Mattick, R. P. (1997). Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction, 92(7), 839–845. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9293043 doi:10.1111/j.1360-0443.1997.tb02953.x
   PubMed Web of Science ®Google Scholar
• UNODC. (2010). World drug report 2010. Retrieved from Vienna.
   Google Scholar
• UNODC. (2012). World Drug Report 2012. Retrieved from Vienna.
   Google Scholar
• UNODC. (2016). World Drug Report 2016. Retrieved from Vienna.
   Google Scholar
• UNODC. (2017). World drug report 2017. Retrieved from
   Google Scholar
• UNODC. (2018). World drug report 2018, global overview of drug demand and supply latest trends, cross-cutting issues.
   Google Scholar
• Van Hout, M. C., & Hearne, E. (2017). User experiences of development of dependence on the synthetic cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. International Journal of Mental Health and Addiction, 15(3), 565–579. doi:10.1007/s11469-016-9650-x
   Web of Science ®Google Scholar
• Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., … Murray, C. J. L. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211–1259. doi:10.1016/S0140-6736(17)32154-2
   PubMed Web of Science ®Google Scholar
• Wazaify, M., Alali, M. B., Yousef, M. A., & Qammaz, S. (2017). Ophthalmic drops abuse in community pharmacy setting: A cross-sectional study from Jordan. Journal of Substance Use, 2017, 1–6. doi:10.1080/14659891.2016.1271041
   Google Scholar
• Weissman, M. M., Greenwald, S., Nino-Murcia, G., & Dement, W. C. (1997). The morbidity of insomnia uncomplicated by psychiatric disorders. General Hospital Psychiatry, 19(4), 245–250. doi:10.1016/S0163-8343(97)00056-X
   PubMed Web of Science ®Google Scholar
• WHO. (2010). ATLAS of substance use disorders, resources for the prevention and treatment of substance use disorders (SUD). Jordan: Country Profile.
   Google Scholar
• WHO. (2015). Disease burden and mortality estimates, Global Health Estimates 2015: deaths by cause, age, sex, by country and by region.
   Google Scholar
• WHO. (2018). Global status report on alcohol and health 2018.
   Google Scholar